Archives

by in
Entry Author Date Location
Alnylam and Glaxo Partner on RNAi for Vaccine Production 11/01/11 Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun) 10/05/11 National
Join Us at 1 pm Eastern/10 am Pacific for RNAi “Tweetchat” with Alnylam’s John Maraganore 10/04/11 National
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam 09/28/11 National
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise 09/19/11 National
Merck Shuts Down RNAi Research Center in SF, Cutting 50 Jobs 07/29/11 San Francisco
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
Alnylam Inks Deal with Precision NanoSystems 04/19/11 Boston
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference 04/14/11 Boston
Westphal Leaving Glaxo, Cubist Settles Patent Litigation with Teva, BSX Buys S.I., & More Boston-Area Life Sciences News 04/08/11 Boston
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News 04/07/11 Seattle
Alnylam Responds to Tekmira Suit 04/06/11 Boston
Christoph Westphal Leaving GSK’s SR One to Focus on Longwood Founders Fund 04/04/11 Boston
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News 03/25/11 Boston
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News 03/24/11 Seattle
Alnylam CEO: Tekmira Accusation of Trade Secret Misuse was a “Big Surprise” 03/18/11 Boston
Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles 03/18/11 Boston
Tekmira Sues Alnylam, Alan Aderem Bolts to Seattle BioMed, Dendreon’s Warhorse Retires, & More Seattle-Area Life Sciences News 03/17/11 Seattle
Tekmira Sues Alnylam for $1 Billion, Accusing Partner of Misusing RNAi Trade Secrets 03/16/11 Boston
Alnylam, UMass, and Others Settle RNAi Patent Litigation 03/15/11 Boston
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders 03/01/11 Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
Page 2 of 8 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.